Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Jul 8, 2024
- Accession no.
- 0001593968-24-000945
- Filed
- Jul 8, 2024
- Trade date
- May 20-Jul 3, 2024
- Filing delay
- 49 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.78K. It was filed 49 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | AGrant or awardAcquired | +2,000 | $7.05 | +$14,100 | 289,773 | Direct | |
| Jul 3, 2024 | Common Stock | SSaleDisposed | −66 | $27.00 | −$1,782 | 289,707 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.